MedPath

safety and efficacy of chlorprocaine(1%) vs chlorprocaine(1%) with 20 microgram fentanyl in subar achnoid block in lower limb ambulatory surgery

Phase 4
Conditions
Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Registration Number
CTRI/2019/05/019143
Lead Sponsor
Department Of Anaesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade: I, II, III

Participants undergoing lower limb surgery under subarachnoid block

duration of surgery-30 to 45 minutes

patients giving written and informed consent

Exclusion Criteria

Participants not giving written and informed consent

participantants not willing for subarachnoid block

participants having contraindications to subarachnoid block like congenital spinal anomalies, altered coagulation profile, local site skin infection

participants having severe psychiatric disorders like depression and dementia

paricipants having neurological disease like brain tumour, cNS syphilis, meningitis

spinal cord and peripheral nerve disease, poliomyelitis, multiple sclerosis

participants with allergy to local anaesthetic drug

drug, alcohol abuse

prenancy

lactationg mother

chronic headache eg. migraine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare onset, peak time and duration of sensory, motor block in both groupsTimepoint: from the time of onset to achievment of peak effect
Secondary Outcome Measures
NameTimeMethod
To measure effect of drug on hemodynamics, complication of drugs and technique, total duration of post operative analgesia and need of resque analgesia within 24 hoursTimepoint: time from subarachnoid injection to first dose of resque analgesic
© Copyright 2025. All Rights Reserved by MedPath